87 related articles for article (PubMed ID: 6509818)
61. Tamoxifen in early breast cancer.
Greenspan EM
Lancet; 1983 Mar; 1(8325):655. PubMed ID: 6131338
[No Abstract] [Full Text] [Related]
62. Tamoxifen with or without chemotherapy?
Smigel K
J Natl Cancer Inst; 1990 Jun; 82(12):1003-4. PubMed ID: 2348466
[No Abstract] [Full Text] [Related]
63. High-dose tamoxifen in metastatic renal cell carcinoma.
Lanteri VJ; Dragone N; Choudhury M; Beckley S; Wajsman Z; Pontes JE
Urology; 1982 Jun; 19(6):623-5. PubMed ID: 7090111
[TBL] [Abstract][Full Text] [Related]
64. Histiocytic lymphoma of breast responds to tamoxifen.
Millis RR; Bobrow LG; Rubens RD; Isaacson PG
Br J Cancer; 1988 Dec; 58(6):808-9. PubMed ID: 3066396
[No Abstract] [Full Text] [Related]
65. Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.
Osborne RJ; Malik ST; Slevin ML; Harvey VJ; Spona J; Salzer H; Williams CJ
Br J Cancer; 1988 Jan; 57(1):115-6. PubMed ID: 3348944
[No Abstract] [Full Text] [Related]
66. NSABP halts B-14 trial: no benefit seen beyond 5 years of tamoxifen use.
J Natl Cancer Inst; 1995 Dec; 87(24):1829. PubMed ID: 7494223
[No Abstract] [Full Text] [Related]
67. Should we embrace or ablate our urge to (ovarian) suppress?
Jankowitz RC; Puhalla S; Davidson NE
J Clin Oncol; 2014 Dec; 32(35):3920-2. PubMed ID: 25366692
[No Abstract] [Full Text] [Related]
68. Are we giving tamoxifen for too long?
Jordan VC
Eur J Cancer; 1991; 27(9):1070-2. PubMed ID: 1835614
[No Abstract] [Full Text] [Related]
69. Carcinoma of the breast also treated by homeopathy.
Trexler HL
J Am Inst Homeopath; 1966; 59(5):165-7. PubMed ID: 5952582
[No Abstract] [Full Text] [Related]
70. Poor response of breast cancer to tamoxifen.
McDonald PJ; Carpenter R; Royle GT; Taylor I
Postgrad Med J; 1990 Dec; 66(782):1029-31. PubMed ID: 2084647
[TBL] [Abstract][Full Text] [Related]
71. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
Jovanović-Mićić D; Beleslin DB; Nikolić SS
Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
[TBL] [Abstract][Full Text] [Related]
72. Tamoxifen in advanced breast cancer.
Mouridsen H; Palshof T; Patterson J; Battersby L
Cancer Treat Rev; 1978 Sep; 5(3):131-41. PubMed ID: 365330
[No Abstract] [Full Text] [Related]
73. A clinical assessment of loading dose tamoxifen for advanced breast carcinoma.
Ribeiro GG; Wilkinson PM
Clin Oncol; 1984 Dec; 10(4):363-7. PubMed ID: 6509818
[TBL] [Abstract][Full Text] [Related]
74. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
[TBL] [Abstract][Full Text] [Related]
75. Tamoxifen in the management of advanced breast carcinoma in Nigerian women.
Senbanjo RO; Ihekwaba FN; Ajayi OO
West Afr J Med; 1990; 9(1):44-9. PubMed ID: 1702986
[TBL] [Abstract][Full Text] [Related]
76. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
Hird RB; Chang A; Cimmino V; Diehl K; Sabel M; Kleer C; Helvie M; Schott A; Young J; Hayes D; Newman L
Cancer; 2006 May; 106(10):2113-8. PubMed ID: 16596655
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
